Breast Cancer



Breast Cancer Recent News

Celcuity Plans To Start Pivotal Gedatolisib Trial In Breast Cancer In 1H 2022
Why Sanofi Shares Are Trading Lower Today
AstraZeneca-Merck's Lynparza Wins FDA Approval For Early-Stage Breast Cancer
NEJM Publication Shows Novartis' Kisqali With Longest Median Overall Survival In Breast Cancer Setting
FDA Backs Immutep's Eftilagimod Registrational Trial In Metastatic Breast Cancer
Gilead Sciences' Trodelvy Study In Breast Cancer Meets Primary Endpoint
AstraZeneca's Stock Gain After Enhertu Meets Primary Endpoint In HER2-Low Breast Cancer Setting
Puma Biotech's Nerlynx Included In NCCN Guidelines For Breast Cancer
Merus Shares Updated Data From Zeno Triplet Combo Data In Breast Cancer Settings
Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial
Arvinas, Pfizer's ARV-471 Shows Clinical Benefit Rate Of 40% In Pretreated Breast Cancer Patients
Context Therapeutics Shares Surge On Encouraging Data From Onapristone In Early Breast Cancer
Ambrx Biopharma Shares Jump After Safety, Efficacy Data From Breast Cancer Trial
Seagen Tukysa Maintains Survival Benefit, Delays Cancer Progression In The Brain In Breast Cancer Patients
Novartis' New Kisqali Data Shows Consistent Overall Survival Benefit Across Metastatic Breast Cancer Settings
Radius Health Reveals Detailed Elacestrant Data From Late-Stage Breast Cancer Trial
After Denying Data Leak, Olema Shares First Data For Lead Program In Breast Cancer Patients
AstraZeneca-Merck's Lynparza Under FDA Priority Review For Breast Cancer Setting
Merck's Keytruda Conditionally Approved In Canada For Triple-Negative Breast Cancer
Gilead's Trodelvy Approved In Europe For Aggressive Form Of Breast Cancer
Athenex To Present Subgroup Analysis Of Oral Paclitaxel-Encequidar Combo Data From Breast Cancer Trial
Jaguar Health's Posts Crofelemer Data For Chemo-Induced Diarrhea In Breast Cancer Patients
Immutep's Lead Candidate Data In Breast Cancer Trial Fails To Lift The Stock